Reference
Johnston SS, et al. Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy. Value in Health 16: 418-25, No. 2, Mar 2013. Available from: URL: http://dx.doi.org/10.1016/j.jval.2012.10.021
Rights and permissions
About this article
Cite this article
Atazanavir cheaper and better tolerated than darunavir. PharmacoEcon Outcomes News 676, 5 (2013). https://doi.org/10.1007/s40274-013-0315-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0315-8